Clinical Trials in New York

Showing 6081-6100 of 17,259 trials

Effects of MK-3475 (Pembrolizumab) on the Breast Tumor Microenvironment in Triple Negative Breast Cancer

NCT02977468

Assess response to pembrolizumab in both primary tumor, normal breast stroma, circulating lymphocytes and serum exosomes in treatment naive triple negative breast cancer (TNBC) patients. Assess for change in tumor-infiltrating lymphocytes (TILS) both stromal (sTILS) and intraepithelial (iTILS) in newly diagnosed early stage TNBC patients treated with two doses of MK-3475 prior to lumpectomy.

Triple Negative Breast Cancer

Eileen Connolly15 participantsStarted Oct 2017

Atlanta, Georgia, United States • Maywood, Illinois, United States • New York, New York, United States

TERMINATEDPhase 2< 1 mile

Open-Label Study of Oral Treprostinil in Digital Ulcers

NCT00848107

This open label extension trial will allow ongoing treatment of subjects who participated in the randomized controlled trials, and will provide long term information about the safety of treprostinil diethanolamine SR in subjects with SSc and digital ulcers.

Systemic Sclerosis

United Therapeutics115 participantsStarted Sep 2009

Birmingham, Alabama, United States • Scottsdale, Arizona, United States • Los Angeles, California, United States +23 more locations

Effects of MK-3475 (Pembrolizumab) on the Breast Tumor Microenvironment in Triple Negative Breast Cancer

Open-Label Study of Oral Treprostinil in Digital Ulcers

Find Trials by Condition in New York

Evaluating the Benefit of Concurrent Tricuspid Valve Repair During Mitral Surgery

Isatuximab in Combination With Cemiplimab in Relapsed/Refractory Multiple Myeloma (RRMM) Patients

Expanded Access Protocol of Teprotumumab (HZN-001) for Patients With Active Thyroid Eye Disease

Real-life Treatment Patterns With Cyclin-dependent Kinase Inhibitors in Advanced Breast Cancer in Portugal - REVEAL Study

Artificial Intelligence Mobile Health Trial Of A Digital Platform To Optimize GDMT Using Wearable Sensors

Open Label Study of KRN23 on Osteomalacia in Adults With X-linked Hypophosphatemia (XLH)

An Extension Study of KRN23 in Adults With X-Linked Hypophosphatemia

Long-term Follow-Up Study of RGX-314 and Fellow Eye Substudy

Study of Efficacy and Safety of CSJ117 in Patients With Severe Uncontrolled Asthma

Phase 2 Spectra Study to Evaluate the Safety and Efficacy of OPL-0401 in Patients With Diabetic Retinopathy

Safety and Efficacy of Intravitreal Injection of Human Retinal Progenitor Cells in Adults With Retinitis Pigmentosa

Study to Demonstrate the Efficacy, Safety and Tolerability of an Intravenous Regimen of Secukinumab Compared to Placebo in Subjects With Active axSpA

Effects of Dapagliflozin in Non-diabetic Patients With Proteinuria

Therapeutic Cancer Vaccine (AST-301, pNGVL3-hICD) in Patients With Breast Cancer

A Study of Replagal in Treatment-naïve Adults With Fabry Disease

A Study to Determine Safety of Durvalumab After Sequential Chemo Radiation in Patients With Unresectable Stage III Non-Small Cell Lung Cancer

Study of Efficacy and Safety of Ligelizumab in Adolescents and Adults With Chronic Inducible Urticaria Who Remain Symptomatic Despite Treatment With H1- Antihistamines

Study of the Safety and Efficacy of LHC165 Single Agent and in Combination With PDR001 in Patients With Advanced Malignancies